Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 7, 2014, Pages 952-957

  Sonn, Geoffrey A ^a,b   Filson, Christopher P ^a   Chang, Edward ^a   Natarajan, Shyam ^a   Margolis, Daniel J ^a   Macairan, Malu ^a   Lieu, Patricia ^a   Huang, Jiaoti ^a   Dorey, Frederick J ^a   Reiter, Robert E ^a   Marks, Leonard S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Active surveillance; Biopsy; Magnetic resonance imaging; Prostatic neoplasms; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; GLEASON SCORE; HUMAN; IMAGE GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION-GUIDED PROSTATE BIOPSY DEVICE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPEAT PROCEDURE; BIOPSY; COMPUTER ASSISTED SURGERY; ENDOSCOPIC ECHOGRAPHY; PROCEDURES; PROSTATIC NEOPLASMS; THREE DIMENSIONAL IMAGING; WATCHFUL WAITING;

BIOPSY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; SURGERY, COMPUTER-ASSISTED; ULTRASONOGRAPHY, INTERVENTIONAL; WATCHFUL WAITING;

EID: 84924126304     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.04.003     Document Type: Article

References (20)

1. Klotz L., Zhang L., Lam A., Nam R., Mamedov A., Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131.
2. Eggener S.E., Mueller A., Berglund R.K., Ayyathurai R., Soloway C. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 2013, 189:S19-S25.
3. Tosoian J.J., Trock B.J., Landis P., et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 2011, 29:2185-2190.
4. Dall'ra M.A., Konety B.R., Cowan J.E., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008, 112:2664-2670.
5. Soloway M.S., Soloway C.T., Williams S., Ayyathurai R., Kava B., Manohara M. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 2008, 101:165-169.
6. Porten S.P., Whitson J.M., Cowan J.E., Perez N., Shinohara K., Carroll P.R. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol 2011, 186:1825-1829.
7. Porten S.P., Whitson J.M., Cowan J.E., et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 2011, 29:2795-2800.
8. Natarajan S., Marks L.S., Margolis D.J., et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol 2011, 29:334-342.
9. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 1998, 280:969-974.
10. Epstein J.I., Allsbrook W.C., Amin M.B., et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005, 29:1228-1242.
11. Brimo F., Vollmer R.T., Corcos J., et al. Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue. Histopathology 2008, 53:177-183.
12. Ahmed H.U., Hu Y., Carter T., et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol 2011, 186:458-464.
13. Bax J., Cool D., Gardi L., et al. Mechanically assisted 3D ultrasound guided prostate biopsy system. Med Phys 2008, 35:5397-5410.
14. Dall'ra M.A., Albertsen P.C., Bangma C., et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012, 62:976-983.
15. Sonn G.A., Chang E., Natarajan S., et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 2014, 65:809-815.
16. Vourganti S., Rastinehad A., Yerram N.K., et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012, 188:2152-2157.
17. Hambrock T., Somford D.M., Hoeks C., et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010, 183:520-527.
18. Penney K.L., Stampfer M.J., Jahn J.L., et al. Gleason grade progression is uncommon. Cancer Res 2013, 73:5163-5168.
19. Karram S., Trock B.J., Netto G.J., et al. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings. Am J Surg Pathol 2011, 35:1351-1355.
20. de Rooij M, Crienen S, Witjes JA, et al. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol 2013. [Epub ahead of print]. http://dx.doi.org/10.1016/j.eururo.2013.12.012.